Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction
Abstract OBJECTIVE: To observe the level in plasma hydrogen sulfide (H2S) and the expression of cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE) (two key synthetases for endogenous H2S generation in the kidney) in obstructed kidney tissue among rats with tubulointerstitial fibrosis (TIF) induced by unilateral ureteral obstruction (UUO), and to explore the role of H2S in TIF. METHODS: Ninety-six male Sprague-Dawley rats were randomly divided into sham-operated, model, low-dose NaHS and high-dose NaHS groups (n=24 each). TIF was induced by UUO in the model, low-dose NaHS and high-dose NaHS groups. The low-dose and high-dose NaHS groups were intraperitoneally injected with NaHS (1.4 and 7.0 μmol/kg respectively) twice daily immediately after operation, and the sham-operated and model groups were intraperitoneally injected with an identical volume of normal saline. In each group, 8 rats were randomly selected and sacrificed at 7, 14 or 21 days after operation. Plasma H2S concentration was measured by deproteinization. The obstructed kidney tissue was subjected to hematoxylin and eosin staining and Masson staining, and the renal tubulointerstitial injury was evaluated under a microscope. mRNA and protein expression of CBS and CSE in the obstructed kidney tissue was measured by RT-PCR and immunohistochemistry respectively. RESULTS: The degree of UUO-induced renal tubulointerstitial injury was negatively correlated with plasma H2S concentration in (r=-0.891, P0.05). CONCLUSIONS: H2S is involved in the development of UUO-induced TIF, and the CBS/H2S and CSE/H2S systems play key roles in this process. H2S supplementation can delay the progression of TIF.
ZHAO De-An,LIU Jun,HUANG Qian et al. Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction[J]. CJCP, 2013, 15(10): 903-908.
ZHAO De-An,LIU Jun,HUANG Qian et al. Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction[J]. CJCP, 2013, 15(10): 903-908.
Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat[J]. Biochem J, 1982, 206(2): 267-277.
[2]
House JD, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat kidney[J]. Biochem J, 1997, 328(Pt1): 287-292.
Nanqaku M. Mechanisms of tubulointerstitial injury in the kindey：final common pathways to end-stage renal failure[J]. Intern Med, 2004, 43(1): 9-17.
[11]
Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, Castiglia S, et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction[J]. Lab Invest, 2008, 88(10): 1038-1048.
[12]
Della Coletta Francescato H, Cunha FQ, Costa RS, Barbosa Junior F, Boim MA, Arnoni CP, et al. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage[J]. Nephrol Dial Transplant, 2011, 26(2): 479-488.
[13]
Perna AF, Luciano MG, Ingrosso D, Raiola I, Pulzella P, Sepe I, et al. Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients[J]. J Ren Nutr, 2010, 20(5): S11-S14.
[14]
Xia M, Chen L, Muh RW, Li PL, Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys[J]. J Pharmacol Exp Ther, 2009, 329(3): 1056-1062.
